3-tyr-octreotide has been researched along with Glioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandyopadhyay, AK; Banerjee, I; Chattopadhyay, S; De, K; Dey, G; Ganguly, S; Gupta, A; Mandal, M; Misra, M; Mukherjee, D; Mukherjee, M | 1 |
1 other study(ies) available for 3-tyr-octreotide and Glioma
| Article | Year |
|---|---|
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Glioma; Lipids; Mice; Nanoparticles; Neovascularization, Pathologic; NIH 3T3 Cells; Octreotide; Paclitaxel; Rats | 2016 |